Cardiovascular Business July 30, 2024
CorVascular, a Minnesota-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for its VasoGuard V-Series portfolio of devices designed to test patients for signs of peripheral artery disease (PAD) and/or peripheral vascular disease (PVD).
The newly cleared devices include the V2, V4, V6, V8 and V10 VasoGuard systems, which are built to help identify signs of PAD and/or PVD in patients when it is still early enough to avoid limb amputation. Each offering includes up to three continuous wave Doppler probes with full color spectrum, up to five wearable photoplethysmography sensors and up to 10 pulse volume recording channels. The devices come with a touchscreen computer, mobile cart and various accessories.
“FDA 510(k) clearance of the...
Today's Sponsors
Today's Sponsor